Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options.
Abdera Therapeutics is growing rapidly and seeking key new team members who thrive at the cutting-edge of innovation. Come join us and be a part of the ground-breaking team set to unlock the power of targeted radiotherapy!
Company Details
- Employees
- 79
- Address
- 901 Gateway Blvd, South San Francisco,california 94080,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.abderatx.com
- HQ
- South San Francisco, California
Abdera Therapeutics Questions
Abdera Therapeutics's website is http://www.abderatx.com
Abdera Therapeutics's LinkedIn profile is https://www.linkedin.com/company/abdera-therapeutics
Abdera Therapeutics has
79 employees.
View email and phone details for 79
employees at Abdera Therapeutics.
Abdera Therapeutics's industry is
Biotechnology Research
Abdera Therapeutics's top competitors are
Attovia Therapeutics,
Kyverna Therapeutics,
Maplight Therapeutics, Inc.,
Cargo Therapeutics,
Xaira Therapeutics,
Editco Bio,
Montara Therapeutics, Inc.,
Structure Therapeutics,
Genista Biosciences,
Genesis Therapeutics.
Abdera Therapeutics's categories are Biotechnology Research
